Healthcare: How Marijuana Legalization Impacted OrganiGram and Aphria's Latest Results
Podcast |
Industry Focus
Publisher |
The Motley Fool
Media Type |
audio
Categories Via RSS |
Business
Business News
News
Publication Date |
Apr 17, 2019
Episode Duration |
00:29:02

Marijuana stocks OrganiGram and Aphria reported quarterly earnings this week - here's what you should know. Also, Abbott locks horns with DexCom in diabetes and what's next for Bristol-Myers' now that its Celgene acquisition is official.

Check out more of our content here:

This episode currently has no reviews.

Submit Review
This episode could use a review!

This episode could use a review! Have anything to say about it? Share your thoughts using the button below.

Submit Review